BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27776115)

  • 1. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
    Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG;
    Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
    Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
    [No Abstract]   [Full Text] [Related]  

  • 3. Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia.
    Potuckova E; Zuna J; Hovorkova L; Starkova J; Stary J; Trka J; Zaliova M
    PLoS One; 2016; 11(8):e0160385. PubMed ID: 27494621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.
    Zhang H; Cheng N; Li Z; Bai L; Fang C; Li Y; Zhang W; Dong X; Jiang M; Liang Y; Zhang S; Mi J; Zhu J; Zhang Y; Chen SJ; Zhao Y; Weng XQ; Hu W; Chen Z; Huang J; Meng G
    Cancer Commun (Lond); 2021 Nov; 41(11):1116-1136. PubMed ID: 34699692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
    Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
    Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
    Vendramini E; Giordan M; Giarin E; Michielotto B; Fazio G; Cazzaniga G; Biondi A; Silvestri D; Valsecchi MG; Muckenthaler MU; Kulozik AE; Gattei V; Izraeli S; Basso G; Te Kronnie G
    Oncotarget; 2017 Jun; 8(26):42398-42413. PubMed ID: 28415578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
    Lilljebjörn H; Henningsson R; Hyrenius-Wittsten A; Olsson L; Orsmark-Pietras C; von Palffy S; Askmyr M; Rissler M; Schrappe M; Cario G; Castor A; Pronk CJ; Behrendtz M; Mitelman F; Johansson B; Paulsson K; Andersson AK; Fontes M; Fioretos T
    Nat Commun; 2016 Jun; 7():11790. PubMed ID: 27265895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD371 cell surface expression: a unique feature of
    Schinnerl D; Mejstrikova E; Schumich A; Zaliova M; Fortschegger K; Nebral K; Attarbaschi A; Fiser K; Kauer MO; Popitsch N; Haslinger S; Inthal A; Buldini B; Basso G; Bourquin JP; Gaipa G; Brüggemann M; Feuerstein T; Maurer-Granofszky M; Panzer-Grümayer R; Trka J; Mann G; Haas OA; Hrusak O; Dworzak MN; Strehl S
    Haematologica; 2019 Aug; 104(8):e352-e355. PubMed ID: 30705095
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.
    Yasuda T; Tsuzuki S; Kawazu M; Hayakawa F; Kojima S; Ueno T; Imoto N; Kohsaka S; Kunita A; Doi K; Sakura T; Yujiri T; Kondo E; Fujimaki K; Ueda Y; Aoyama Y; Ohtake S; Takita J; Sai E; Taniwaki M; Kurokawa M; Morishita S; Fukayama M; Kiyoi H; Miyazaki Y; Naoe T; Mano H
    Nat Genet; 2016 May; 48(5):569-74. PubMed ID: 27019113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression.
    Cheng L; Zeng S; Yan D; Tu L; Yang Y; Wang X; Zheng X
    Leuk Res; 2021 Oct; 109():106649. PubMed ID: 34271301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
    Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
    Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of DUX4/IGH-driven transactivation.
    Dong X; Zhang W; Wu H; Huang J; Zhang M; Wang P; Zhang H; Chen Z; Chen SJ; Meng G
    Leukemia; 2018 Jun; 32(6):1466-1476. PubMed ID: 29572508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
    Stankiewicz MJ; Crispino JD
    Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion and maintenance of leukemia by ERG.
    Tsuzuki S; Taguchi O; Seto M
    Blood; 2011 Apr; 117(14):3858-68. PubMed ID: 21321361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.
    Jakobczyk H; Jiang Y; Debaize L; Soubise B; Avner S; Sérandour AA; Rouger-Gaudichon J; Rio AG; Carroll JS; Raslova H; Gilot D; Liu Z; Demengeot J; Salbert G; Douet-Guilbert N; Corcos L; Galibert MD; Gandemer V; Troadec MB
    Leukemia; 2022 Feb; 36(2):549-554. PubMed ID: 34535762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
    Diedrich JD; Dong Q; Ferguson DC; Bergeron BP; Autry RJ; Qian M; Yang W; Smith C; Papizan JB; Connelly JP; Hagiwara K; Crews KR; Pruett-Miller SM; Pui CH; Yang JJ; Relling MV; Evans WE; Savic D
    Leukemia; 2021 Nov; 35(11):3078-3091. PubMed ID: 33714976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG Expression is Helpful in Differentiating T-Lymphoblastic Lymphoma from Thymoma.
    Huang W; Zhang W; Zeng L; Liao S; Liu F; Li L
    Int J Surg Pathol; 2023 Apr; 31(2):137-141. PubMed ID: 35435050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias.
    Tursky ML; Beck D; Thoms JA; Huang Y; Kumari A; Unnikrishnan A; Knezevic K; Evans K; Richards LA; Lee E; Morris J; Goldberg L; Izraeli S; Wong JW; Olivier J; Lock RB; MacKenzie KL; Pimanda JE
    Leukemia; 2015 Apr; 29(4):819-27. PubMed ID: 25306899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.